other_material
confidence high
sentiment negative
materiality 0.95
Iterum Therapeutics to be delisted from Nasdaq on April 1 after winding-up petition
Iterum Therapeutics plc
- Nasdaq will suspend ITRM shares at open on April 1, 2026; Form 25-NSE to follow.
- Company withdrew its appeal of the prior delisting determination after filing winding-up petition on March 27, 2026.
- Joint provisional liquidators Damien Murran and Jennifer McMahon (Teneo) appointed; company in provisional liquidation.
- Iterum will not file Form 10-K for FY 2025 or any future SEC reports due to limited cash resources and winding-up process.